메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

ACROBiosystems and Partners Conclude OrganoAsia 2025

- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization TOKYO, Oct. 10, 2025 -- ACROBiosystems, together with Leica Biosystems, Molecular Devices, and Leica Microsystems, hosted the OrganoAsia 2025-The Frontier of Organoid Science in Beijing. The hybrid-format conference featured an in-person opening session alongside a live online stream, drawing more than 500 experts and researchers—primarily from China, Japan, and South Korea, with additional global attendees—to examine recent progress and future directions for organoid technol
- 김갑성 기자
- 2025-10-10 09:21
Yup、東南アジアの「Nubank」がC-1ラウンドで3,200万ドルを調達、総資本調達額が1億ドルを超える

[ 메디채널 황정호 기자 ] シンガポール、2025年10月10日 -- 東南アジアのデジタル銀行Yupはこのほど、C-1ラウンドを通じて最新の株式資金調達で3,200万ドルを確保しました。この資金調達には、Moore Strategic Ventures、Spice Expeditions、Platanusなどの米国投資会社が支援し、他の機関投資家や既存株主も参加しています。同社にとって、顧客基盤の拡大と収益性向上に向けた取り組みを加速させる上で、今回の資金調達はきわめて重要な節目となります。 Yupは2021年の創業以来、堅調な財務実績と着実な成長を示し、東南アジアのフィンテック分野における最も有望なプラットフォームの1つとしての地位を確立しています。同社は現在、何百万人ものクレジット・カード保有者にサービスを提供しており、2025年末までに損益分岐点に達すると予想しています。これは、事業運営の規律と強力な市場需要の両方を反映した成果です。 Yupは、財務実績にとどまらず、東南アジアの銀行口座を保有せず十分なサービスを受けられていない人々に対して、手頃な価格でテクノロジー主導の金融サービスへのアクセスを拡大することで、金融包摂を推進しています。同社は、労働者階級および中流階級の消費者に信頼性の高いクレジットおよびデジタル・バン
- 황정호 기자
- 2025-10-10 09:00
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year

SHANGHAI, Oct. 10, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year. This top-tier rating by MSCI, a premier global data provider of ESG ratings and research, places WuXi Biologics among an elite group of companies globally recognized for outstanding ESG performance, and acknowledges the company's strong leadership in advocating sustainability, particularly in the key areas of clim
- 김갑성 기자
- 2025-10-10 08:30
Forbidden gates swing open

BEIJING, Oct. 10, 2025 -- A report from China Daily: Meridian Gate towers above the entrance to the Palace Museum in Beijing, once China's imperial palace from 1420 to 1911 and also known as the Forbidden City. During the imperial years, numerous royals, high officials and nobles walked through this gate, which stands for solemnity, ritual and order. They stepped into a "forbidden" place, closed to outsiders where the course of their own destinies — and often the fate of the country — was shaped. In October 1925, a new chapter opened when the Palace Museum was
- 김장윤(JASON KIM) 기자
- 2025-10-10 08:00
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)

EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR) Celltrion plans to enter the U.S. ophthalmology market to meet diverse needs of patients suffering from various eye conditions INCHEON, South Korea, Oct. 10, 2025 -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
- 김갑성 기자
- 2025-10-10 06:56
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research

[ 메디채널 김갑성 기자 ] New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 10, 2025 -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies. This first-of-its-kind assay is the only brain-derived single-plex s
- 김갑성 기자
- 2025-10-10 05:23
Amcor Appoints Stephen R. Scherger as Executive Vice President and Chief Financial Officer

Michael Casamento to return home to Australia to be closer to his family on a full-time basis; Will leave the Company as a result, remaining in an advisory role until June 30, 2026 to support transition Company reaffirms Fiscal 2026 and first quarter Fiscal 2026 outlook ZURICH, Oct. 10, 2025 -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in consumer packaging and dispensing solutions for Nutrition, Health, Beauty and Wellness, announced the appointment of Stephen R. Scherger as Executive Vice President and Chief Financial Officer, effective Nov. 10, 2025. Mr. Scherger succeeds
- 황정호 기자
- 2025-10-10 04:30
POMDOCTOR LIMITED Announces Closing of Initial Public Offering

GUANGZHOU, China, Oct. 10, 2025 -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company. The ADSs began trading on Nasdaq Global Market on October 8, 2025 under the ticker symbol "POM." The Co
- 김갑성 기자
- 2025-10-10 04:05
Over 30,000 Eggs Donated to Help Women in Crisis This World Egg Day

[ 메디채널 황정호 기자 ] Australian Eggs is donating 31,200 eggs to social enterprise Two Good Co to help nourish women in crisis TV personalities Khanh Ong and Alice Zaslavsky will lead a cook-up alongside the Two Good team Donation will contribute to Two Good Co's yearly delivery of 30,000 nutritious meals for vulnerable women SYDNEY, Oct. 10, 2025 -- Australian Eggs are marking World Egg Day by donating a year's worth of eggs (31,200) to social enterprise Two Good Co, helping deliver 30,000 nutritious meals to women in crisis. With eggs back in strong supply, the initiative ensures t
- 황정호 기자
- 2025-10-10 04:00
GEDUグループ、インド最大の外国資本による教育投資家に

ムンバイ（インド）, 2025年10月10日 -- 英国の大手教育事業者であるGEDU Global Educationは、今後3年間でさらに2億ポンドを追加投資し、1,500人の雇用を創出することで、インドにおける最大の海外直接投資家となることを発表しました。この発表は、英国のKeir Starmer首相がムンバイを訪問した際に行われました。同氏は、最近署名された英印自由貿易協定および包括的戦略的パートナーシップの大きな利益を示すためにインドを訪問しており、これらの協定では教育分野と、その英国とインドのパートナーシップの潜在力を引き出す上での重要な役割に大きな重点が置かれています。 GEDUはすでに2,500万ポンドを投資し、認定インフラおよびソリューションプロバイダーとしてのグジャラート州GIFTシティーのキャンパス、600名体制のNoidaのグローバル・センター・オブ・エクセレンス、そしてGEDUの創設者であるRana博士がインドの農村地域で高等教育を提供する慈善事業として設立したウッタルプラデーシュ州のLokmani高等教育機関を設立しています。本日発表された拡張計画には、名門校であるクイーン・エリザベス・スクール・バーネットとの提携が含まれており、この提携を通じて来年8月にデリー首都圏に分校が開設される予定です。2028年
- 황정호 기자
- 2025-10-10 02:40

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2025-11-03_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 03일 17시 20분